New treatment option offering hope to cancer sufferers at NIIM

New treatment option offering hope to cancer sufferers at NIIM

Date: 05-09-2012

The recently launched NIIM 2012 Hyperthermia Study, Australia’s first study examining the effects of Hyperthermia as an adjunctive cancer treatment is anticipated to replicate the high success rates of previous studies with minimal risk, thereby pioneering another tool in the battle against cancer.

The Morestep Hyperthermia System, state-of-the-art technology, provides a further option as an adjunctive treatment for cancer alongside conventional therapies, such as chemotherapy and radiotherapy.

Purchase of the Morestep NRL-003 Hyperthermia System was made possible through the generosity of David Bardas and the Bardas Family Foundation, making NIIM Clinic Melbourne’s first Hyperthermia cancer treatment facility.

 

In acknowledgement of their father’s generosity and the family’s philanthropic culture, Belinda and Elli Bardas said: “Setting an example and inspiring others to give is Dad’s way of showing his gratitude and giving hope to others. We are behind him 100 percent.”

Cancer patients in Australia can now breathe a sigh of relief knowing that they do not have to travel across the globe to seek Hyperthermia Treatments, until today only available in Europe, the USA and some parts of Asia.

According to Andrea Saville, wife of Hyperthermia patient, Tom: “This place (NIIM) saved Tom’s life, we are forever grateful and spreading the word.” This is true testament of the great work that will be formally ratified through the Hyperthermia Study.

Special guests attending the launch included Professor Iain Wallace; Deputy Lord Mayor, Cr Susan Riley; Boroondara Council’s Cr Jack Wegman; David, Belinda and Elli Bardas, and other guests.